UNSPSC 51151619: Anisotropine

This classification denotes an antimuscarinic agent with the molecular formula C16H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MJJ5G1G8OM. As of Q4 2014, ANISOTROPINE remains the US FDA Preferred Term for this commodity. Anisotropine bears US NLM identifiers UMLS ID C0301369 and NCI Concept Code C87426. SMILES: CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[BR-]..

UNSPSC 51151619 Anisotropine is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though recent solicitation activity under this code shows minimal alignment with the nominal product scope. Seminole County, Florida posted an IFB in mid-2026 for naloxone and drug deactivation systems — a public-health emergency-response purchase fundamentally distinct from anisotropine, an anticholinergic medication. State and local buyers using this code appear to span county health departments and possibly municipal public-health agencies, though the recent record is too sparse to characterize the issuing-body mix or identify repeat buyers.

Geographic activity is concentrated in Florida based on the single recent opportunity. Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option and requires E-Verify compliance, drug-free workplace certification, and standard commercial insurance. The mismatch between the code's pharmaceutical name and the naloxone-focused solicitation suggests either miscoding by the issuing body or a broader code usage for emergency-response pharmaceuticals and related systems. Verify alignment with your product line before pursuing activity under this code.